Zobrazeno 1 - 10
of 66
pro vyhledávání: '"J. H. Joist"'
Publikováno v:
Scandinavian Journal of Haematology. 33:149-160
In view of reports of less than labelled F VIII:C content in some lots of commercially available f VIII concentrates, a multi-center prospective study of f VIII concentrate potency was organized in collaboration with the United States Bureau of Biolo
Publikováno v:
Letters in Drug Design & Discovery. 3:481-487
Publikováno v:
Haemophilia. 8:136-141
Formation of destructive haemorrhagic pseudocysts or pseudotumours thought to arise from unresolved, encapsulated haematomas is a well-recognized, rare complication of severe haemophilia A or B, and has been reported in a single patient with von Will
Autor:
J H Joist, George J. Despotis
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 13:18-29
Accelerated thrombin generation is central to the development of hemostatic abnormalities during cardiopulmonary bypass (CPB) that are associated with both thromboembolic complications and serious, abnormal bleeding. Thrombin not only converts fibrin
Publikováno v:
Seminars in Thrombosis and Hemostasis. 25:407-418
Blood coagulation occurs efficiently on cell surfaces such as activated platelets and monocytes, and fibroblasts. It is initiated by limited amounts of tissue factor (TF) exposed at the sites of vascular injury that complexes with trace amounts of ci
Autor:
H. R. Roberts, H. Smith, Y. Laurian, G. Davignon, Carol K. Kasper, A. Shapiro, J. H. Joist, P. M. Mannucci, Jeanne M. Lusher
Publikováno v:
Haemophilia. 4:790-798
Recombinant factor VIIa (rFVIIa) was developed to provide an improved procoagulant component capable of 'by-passing' inhibitor antibodies in the treatment of haemophilic patients. The primary objective of this study was to compare the efficacy of two
Publikováno v:
Anesthesia & Analgesia. 85:498-506
This study was designed to determine if, and to what extent, antithrombin III (AT) levels affect the response of the activated clotting time (ACT) to heparin in concentrations used during cardiac surgery, and to characterize the relationship between
Publikováno v:
Anesthesia & Analgesia. 84:479-483
Previous studies have demonstrated that heparin concentrations during cardiopulmonary bypass (CPB) may vary considerably, which may be related to variability in redistribution, cellular and plasma protein binding, and clearance of heparin. The purpos
Autor:
Lawrence T. Goodnough, Alexander Alsoufiev, Edward L. Spitznagel, M. Rosenblum, Samuel A. Santoro, J. H. Joist, Kathy M. Kater, Charles W. Hogue, G. J. Despotis, D. G. Lappas
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 110(1):46-54
A whole blood hemostasis system (Hepcon) provides both activated clotting time and accurate whole blood heparin concentration measurements via an automated protamine titration method. This study was designed to prospectively evaluate the impact of he
Autor:
A. L. Summerfield, J. H. Joist, James Lewis Cox, G. J. Despotis, Lawrence T. Goodnough, E. Spitznagel, D. G. Lappas, Samuel A. Santoro
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 108:1076-1082
Previous reports suggest that activated clotting times do not correlate with heparin concentration during cardiopulmonary bypass. This study was designed to compare whole blood heparin concentration and activated clotting time measurements with labor